DONATE

Bioengineering in reproductive health

Samuel Ojosnegros Martos
Head of Bioengineering in Reproductive Health

ABOUT

Our lab’s focus is on understanding the mechanisms that control mammalian embryo implantation and apply that knowledge to provide solutions that improve human assisted reproduction techniques (ART).

The embryonic development of humans (and mammals in general) requires the implantation of the embryo into the walls of the maternal uterus. This process is highly inefficient as on average, 25–30% of conceptions lead to successful live births and around 60% of all conceptions are lost at the time of (or soon after) implantation. However, despite the central role of implantation in human fertility, the process is still elusive to experimentation because of its inaccessibility.

To overcome the elusiveness of this process, the group combines imaging and bioengineering methods to efficiently culture and image pre-implantation embryos and allow them to implant outside the uterus in highly physiological conditions.  Our systems are accessible to imaging tools which allow us to interrogate the genetics, metabolomics, and mechanics of the embryo in a high throughput manner. Using our systems, we are capable to (i) improve embryo culture conditions and (ii) diagnose embryos with improved implantation potential.

Label-free microscopy and multi/hyperspectral imaging

Label-free Microscopy: This technique allows for analyzing cells in their native condition, i.e. without being labeled or altered in any way, by means of retrieving cells autofluorescence signals and thus providing essential metabolic information about living tissues. Combined with multispectral methods, we delve deep into the metabolic complexity of embryos and oocytes, revealing insights previously unattainable.

Hyperspectral Imaging: Our groundbreaking approach employs hyperspectral imaging to obtain the metabolic profiles of embryos and oocytes. This methodology allows us to identify key characteristics at the metabolic level, invisible to conventional techniques like brightfield imaging, offering a unique window into fundamental biological processes.

Hardware Techniques: We have extensive expertise in a variety of advanced microscopy techniques, including two-photon microscopy, laser scanning confocal microscopy, spinning disk confocal microscopy and light-sheet microscopy. The integration of these techniques with multi/hyperspectral detection methods enables us to observe biological samples of interest at cellular level with spectral characteristics.

AI and Software Analysis: We employ sophisticated data analysis tools such as spectral histogram analysis and phasor-plot analysis combined with artificial intelligence (AI) methods for classification. These techniques allow us to interpret complex multi/hyperspectral data and draw meaningful conclusions about the viability and quality of embryos and oocytes.

4D (x, y, z, and λ) Hyperspectral Autofluorescent Images of Mouse Oocytes and Blastocysts. The samples were imaged using a Zeiss LSM780 inverted microscope with a C-Apochromat 40x/1.20 W Korr Zeiss objective. The imaging conditions were maintained at 37°C and 5% CO2. A Mai-Tai DeepSee laser provided two-photon excitation at a wavelength λex = 780nm. The emitted autofluorescence spanned from 410 nm to 695 nm and was collected by a 32-channel PMT GaAsP spectral detector. The image captures multiple planes, separated by 2.5μm and 5μm steps for oocytes and embryos respectivelly. The pseudo-color representation of the hyperspectral images was achieved using additive blending to integrate the 32 channel colors for each pixel.

Bioengineering to improve embryo implantation

We have developed proprietary 3D ex vivo hydrogel-based implantation platforms which mimic the uterine microenvironment, allowing the embryo to progress towards post-implantation stages in an amenable way for optical microscopy. Working towards obtaining dynamic control of embryo culture, we have integrated our hydrogels in a microfluidic device allowing for controlled nutrient supply, oxygen concentration and long-term embryo culture. Our 3D ex vivo hydrogel-based implantation platforms allow for drug screening and determination of its impact on embryo implantation and development.

We use our 3D ex vivo implantation platform to understand embryo implantation with a focus on the biomechanics of the system. To this means we quantify the displacement of the matrix generated by the embryos using PIV or DVC algorithms. We look at the forces and resulting patterns embryos are applying in order to penetrate the hydrogel and also how external forces affect embryo implantation.

Human Embryo implanting on a 3D platform (video)

Embryo Culture Supplements Development from Human Plasma

Traditionally, embryo culture relied on Human Serum Albumin (HSA) as a key protein component. However, HSA underrepresents the rich composition of proteins present in human plasma. We work with a new-generation of supplements, which go beyond mere albumin, encompassing essential components such as growth factors and globulins, crucial for fostering optimal embryo development. In our group, we test new supplements to enhance embryo development and implantation. Our clinical grade human-derived supplements improve blastulation and implantation rates both in human and mouse embryos, showing superior lineage segregation and spatial organization compared to control counterparts.

The Bioengineering in Reproductive Health is the first Open Innovation Lab research unit at IBEC.

Due to the high translational component of our research, we have established collaboration contracts with the pharma industry, hospitals, and venture capital to bring our technology to the clinics and the market. Our Open Lab is a multidisciplinary environment where embryologists, cell biologists, optical physicists, biophysicists, and business developers synergize to create a unique environment shaped by science and entrepreneurship.

STAFF

PROJECTS

European Projects
HSMe-ImPredict · Development of non-invasive imaging methodology for improving embryo implantation prediction, via hyper-spectral metabolic profiling (2022-2024)Marie Curie Individual FellowshipSamuel Ojosnegros
National projects
HYSPLANT · Selección de embriones para fecundación in vitro: predicción del éxito de implantación mediante clasificación metabólica de embriones (2020-2023)MINECO
Retos investigación: Proyectos I+D
Samuel Ojosnegros
Prediction of implantation success by hyperspectral metabolic profiling of human embryos obtained by in vitro fertilization (2020-2022)AGAUR
Beatriu de Pinós 2018
Samuel Ojosnegros
Private sector
Estudio del mecanismo de acción de OXO-001 (2020-2022)OxolifeSamuel Ojosnegros
Evaluación de derivados plasmáticos humanos para el cultivo de embriones (2019-2021)IVFTECH S.L.Samuel Ojosnegros
Evaluación de derivados plasmáticos humanos para el cultivo de células mesenquimales y CAR-T (2020-2022)IVFTECH S.L.Samuel Ojosnegros
Prediction of implantation success by single-cell transcriptomic profiling of human embryos obtained by in vitro fertilization (2018-2022)Scranton Enterprises BVSamuel Ojosnegros
Finished projects
HYSPLANT · Metabolic profiling of in vitro fertilization embryos using hyspectral imaging (2019-2020)European Commission ATTRACTSamuel Ojosnegros
Embryo on a chip: Smart microdevice development for high-throughput screening embryo implantation (2020)Tecniospring 2020Maria Demestre Viladevall

NEWS

 

El grupo Bioingeniería en salud reproductiva del Instituto de Bioingeniería de Cataluña (IBEC) aparece a los medios por su participación en el desarrollo de un dispositivo que ofrezca información metabólica del óvulo antes de criopreservar-lo. … Read more

Desarrollan una técnica pionera para saber si un óvulo es bueno

El grupo Bioingeniería en salud reproductiva del Instituto de Bioingeniería de Cataluña (IBEC) aparece a los medios por su participación en el desarrollo de un dispositivo que ofrezca información metabólica del óvulo antes de criopreservar-lo. … Read more

El proyecto HYLIGHT, coordinado por Samuel Ojosnegros del IBEC, ha sido seleccionado para la fase 2 de la convocatoria ATTRACT, una iniciativa de la Unión Europea para impulsar la transferencia de tecnologías con gran potencial de los laboratorios a la sociedad. El proyecto será financiado con cerca de 2 millones de euros durante 26 meses y tiene como objetivo desarrollar un dispositivo de diagnóstico para seleccionar embriones basándose en sus perfiles metabólicos y aumentar las tasas de éxito de las técnicas de fertilización in vitro.

Investigadores del IBEC forman parte del proyecto europeo ATTRACT para desarrollar un dispositivo de diagnóstico que mejore la selección de embriones para los procedimientos de fertilización in vitro

El proyecto HYLIGHT, coordinado por Samuel Ojosnegros del IBEC, ha sido seleccionado para la fase 2 de la convocatoria ATTRACT, una iniciativa de la Unión Europea para impulsar la transferencia de tecnologías con gran potencial de los laboratorios a la sociedad. El proyecto será financiado con cerca de 2 millones de euros durante 26 meses y tiene como objetivo desarrollar un dispositivo de diagnóstico para seleccionar embriones basándose en sus perfiles metabólicos y aumentar las tasas de éxito de las técnicas de fertilización in vitro.

El projecto REACT, liderado por el Statens Serum Institut de Dinamarca, cuenta con la participación del Instituto de Bioingeniería de Cataluña (IBEC) que, con un presupuesto cercano al millón de euros de un total de siete, generará organoides epiteliales nasales humanos específicos como plataformas de validación y modelos preclínicos para investigar la interacción huésped-patógeno .

El IBEC recibe cerca de un millón de euros para estudiar las enfermedades respiratorias graves causadas por virus

El projecto REACT, liderado por el Statens Serum Institut de Dinamarca, cuenta con la participación del Instituto de Bioingeniería de Cataluña (IBEC) que, con un presupuesto cercano al millón de euros de un total de siete, generará organoides epiteliales nasales humanos específicos como plataformas de validación y modelos preclínicos para investigar la interacción huésped-patógeno .

Más de trescientos expertos internacionales en el campo de la investigación en terapias regenerativas se citaron en el simposio organizado por el Instituto de Bioingeniería de Catalunya (IBEC) para presentar los últimos avances en miniórganos, órganos en un chip, bioimpresión 3D e ingeniería de tejidos, entre otros.

Las terapias regenerativas del futuro confluyeron en el Simposio IBEC, con expertos internacionales y más de 300 inscritos

Más de trescientos expertos internacionales en el campo de la investigación en terapias regenerativas se citaron en el simposio organizado por el Instituto de Bioingeniería de Catalunya (IBEC) para presentar los últimos avances en miniórganos, órganos en un chip, bioimpresión 3D e ingeniería de tejidos, entre otros.

Oxolife, la startup biotecnológica focalizada en el desarrollo de fármacos para la mejora de la fertilidad femenina, y el Laboratorio de Bioingeniería en Salud Reproductiva del Instituto de Bioingeniería de Cataluña (IBEC), combinarán dos tecnologías pioneras para el estudio y tratamiento de la infertilidad.

IBEC y Oxolife inician un estudio pionero para tratar la infertilidad

Oxolife, la startup biotecnológica focalizada en el desarrollo de fármacos para la mejora de la fertilidad femenina, y el Laboratorio de Bioingeniería en Salud Reproductiva del Instituto de Bioingeniería de Cataluña (IBEC), combinarán dos tecnologías pioneras para el estudio y tratamiento de la infertilidad.

Application Deadline: 15/07/2020Ref: SR-SO The Bioengineering in reproductive health group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Senior Scientist to develop a project in collaboration with the industry. The project involves investigate the molecular mechanisms affected by specific chemical treatments on endometrial receptivity and on mouse and human embryos in culture. We aim to combine the expertise in microscopy of the lab with embryology tools to understand the morphological and molecular modifications that lead to an increase in endometrial receptivity. An ideal candidate will have experience in the mouse or human embryology field and will know basic tools of molecular biology. The candidate will have a great degree of independence to coordinate the project, competitive salary and funding to outsource several tests (i.e. sequencing, histology etc.). Our laboratory is a multidisciplinary environment where biologists, biophysicists, clinicians and business developers synergize to create a unique environment shaped by science and entrepreneurship. Due to the high translational component of our research, we have established collaboration contracts with the pharma industry, hospitals and venture capital to bring our technology to the clinics and the market. In our lab we use bioengineering methods to create 3D environments that support embryonic development outside of the mother uterus. Our systems are accessible to imaging tools which allow us to interrogate the genetics, metabolomics and mechanics of the embryo in a high throughput manner. Using our systems we are capable to (i) improve embryo culture conditions and (ii) diagnose embryos with improved implantation potential.

Senior researcher at the Bioengineering in Reproductive Health Research Group

Application Deadline: 15/07/2020Ref: SR-SO The Bioengineering in reproductive health group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Senior Scientist to develop a project in collaboration with the industry. The project involves investigate the molecular mechanisms affected by specific chemical treatments on endometrial receptivity and on mouse and human embryos in culture. We aim to combine the expertise in microscopy of the lab with embryology tools to understand the morphological and molecular modifications that lead to an increase in endometrial receptivity. An ideal candidate will have experience in the mouse or human embryology field and will know basic tools of molecular biology. The candidate will have a great degree of independence to coordinate the project, competitive salary and funding to outsource several tests (i.e. sequencing, histology etc.). Our laboratory is a multidisciplinary environment where biologists, biophysicists, clinicians and business developers synergize to create a unique environment shaped by science and entrepreneurship. Due to the high translational component of our research, we have established collaboration contracts with the pharma industry, hospitals and venture capital to bring our technology to the clinics and the market. In our lab we use bioengineering methods to create 3D environments that support embryonic development outside of the mother uterus. Our systems are accessible to imaging tools which allow us to interrogate the genetics, metabolomics and mechanics of the embryo in a high throughput manner. Using our systems we are capable to (i) improve embryo culture conditions and (ii) diagnose embryos with improved implantation potential.

Application Deadline: 30/06/2020Ref: LT-SO The Bioengineering in Reproductive Health Group offers a lab technician position for an experienced cell culture technician to develop a project in collaboration with the industry. The project involves testing the effects of different cell culture supplements on several cell types (e.g. Mesenchymal Stromal Cells, CAR T Cells, etc.) Our laboratory is a multidisciplinary environment where biologists, biophysicists, clinicians and business developers synergize to create a unique environment shaped by science and entrepreneurship. Due to the high translational component of our research, we have established collaboration contracts with the pharma industry, hospitals and venture capital to bring our technology to the clinics and the market. In our lab, we develop high-tech projects in the fields of embryology, cell biology and imaging. Our strategy involves the development of new products for the pharmaceutical industry. The current position seeks a motivated cell culture technician with experience in diverse cell culture systems.

Cell culture lab technician at the Bioengineering in Reproductive Health Research Group

Application Deadline: 30/06/2020Ref: LT-SO The Bioengineering in Reproductive Health Group offers a lab technician position for an experienced cell culture technician to develop a project in collaboration with the industry. The project involves testing the effects of different cell culture supplements on several cell types (e.g. Mesenchymal Stromal Cells, CAR T Cells, etc.) Our laboratory is a multidisciplinary environment where biologists, biophysicists, clinicians and business developers synergize to create a unique environment shaped by science and entrepreneurship. Due to the high translational component of our research, we have established collaboration contracts with the pharma industry, hospitals and venture capital to bring our technology to the clinics and the market. In our lab, we develop high-tech projects in the fields of embryology, cell biology and imaging. Our strategy involves the development of new products for the pharmaceutical industry. The current position seeks a motivated cell culture technician with experience in diverse cell culture systems.

Santiago Marco, investigador principal del grupo de Procesamiento de señales e información para sistemas de sensores y Samuel Ojosnegros, responsable de la unidad Bioingeniería en Salud Reproductiva, han sido seleccionados por sus proyectos de investigación en la convocatoria del programa ATTRACT. La convocatoria recibió más de 1200 propuestas de las cuales se seleccionaron 170. El programa ATTRACT es un proyecto pionero de investigación e innovación que forma parte del programa Horizon 2020 financiado por la Unión Europea y respaldado por un consorcio formado por 9 socios. El objetivo principal de este programa es crear un ecosistema de innovación conjunta entre la investigación fundamental y las comunidades industriales para desarrollar tecnologías avanzadas de detección e imagen para usos científicos y comerciales.

Dos proyectos del programa ATTRACT para investigadores del IBEC

Santiago Marco, investigador principal del grupo de Procesamiento de señales e información para sistemas de sensores y Samuel Ojosnegros, responsable de la unidad Bioingeniería en Salud Reproductiva, han sido seleccionados por sus proyectos de investigación en la convocatoria del programa ATTRACT. La convocatoria recibió más de 1200 propuestas de las cuales se seleccionaron 170. El programa ATTRACT es un proyecto pionero de investigación e innovación que forma parte del programa Horizon 2020 financiado por la Unión Europea y respaldado por un consorcio formado por 9 socios. El objetivo principal de este programa es crear un ecosistema de innovación conjunta entre la investigación fundamental y las comunidades industriales para desarrollar tecnologías avanzadas de detección e imagen para usos científicos y comerciales.

El Instituto de Bioingeniería de Catalunya (IBEC) firma un acuerdo por una ronda de inversión inicial de un millón y medio de euros con Scranton Entreprises B.V. -una asociación de inversión con sede en los Países Bajos-, con el fin de desarrollar tecnología que prediga la probabilidad de implantación de embriones obtenidos mediante fecundación in vitro. Este acuerdo es el primero que se establece en el marco de la nueva iniciativa del instituto, el Open Innovation Lab, que ofrece a empresas e inversores una plataforma para llevar más ágilmente la investigación de vanguardia a los pacientes y al mercado.

El IBEC firma un acuerdo por 1.5 millones de euros con Scranton Enterprises

El Instituto de Bioingeniería de Catalunya (IBEC) firma un acuerdo por una ronda de inversión inicial de un millón y medio de euros con Scranton Entreprises B.V. -una asociación de inversión con sede en los Países Bajos-, con el fin de desarrollar tecnología que prediga la probabilidad de implantación de embriones obtenidos mediante fecundación in vitro. Este acuerdo es el primero que se establece en el marco de la nueva iniciativa del instituto, el Open Innovation Lab, que ofrece a empresas e inversores una plataforma para llevar más ágilmente la investigación de vanguardia a los pacientes y al mercado.

JOBS

PUBLICATIONS

S Ojosnegros, A Seriola, AL Godeau, A Veiga (2021) Embryo implantation in the laboratory: an update on current techniques. Human Reproduction Update, Vol.00, No.0, pp. 1–30.

Martin Plöschner, Denitza Denkova, Simone De Camillis, Minakshi Das, Lindsay M. Parker, Xianlin Zheng, Yiqing Lu, Samuel Ojosnegros, and James A. Piper (2020) Simultaneous super-linear excitation-emission and emission depletion allows imaging of upconversion nanoparticles with higher sub-diffraction resolution. Optics Express 28 (16), 24308-24326.

EQUIPMENT

  • Embryo culture laboratory
    • IFV workstations in laminar flow hoods
    • Microscope
    • Micromanipulation-microinjection station
    • Embryo biopsy laser
    • K-systems incubator
  • Cell culture laboratory
    • Biosafety cabinets
    • Incubators
    • Automated cell counter
    • Dry warming/thawing system
    • Sterile tubing welder
    • Tubing sealer
    • Centrifuges
  • Advanced live imaging: photoconversion, 3D imaging, light scattering, spectroscopy
    • Crest spinning disk mounted on a Nikon Ti
    • Image analysis workstation

COLLABORATIONS

  • Prof. Anna Veiga – Barcelona Stem Cell Bank (IDIBELL) and Dexeus Mujer, Barcelona
  • Dr. Montserrat Boada/ Dr. Pere Barri – Dexeus Mujer, Barcelona
  • Dr. Ayelet Lesman – Tel Aviv University (TAU), Israel
  • Dr. Elena Martínez – IBEC
  • Dr. Francesco Cutrale, University of Southern California (USC), USA
  • Dr. Manuel Irimia – CRG, Barcelona
  • Dr. Javier Ramón – IBEC

ENTREPRENEURSHIP

· Jorge Fuentes,
   Business Strategy, A_Ventures, Barcelona, Spain

  

 

Follow us on Twitter: @Biorephealth